HIV-infection Clinical Trial
Official title:
A Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy
The mai purpose of the study is to evaluate the safety and to establish the recommended dose of iHIVARNA-01 as a new therapeutic vaccine against HIV
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02489487 -
Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500
|
Phase 1 | |
| Completed |
NCT02291081 -
A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients
|
||
| Completed |
NCT01187719 -
The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance
|
Phase 2 | |
| Completed |
NCT02486133 -
Dual Therapy With Boosted Darunavir + Dolutegravir
|
Phase 3 | |
| Completed |
NCT02489435 -
Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT01397669 -
Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais With HIV Infection
|
N/A | |
| Completed |
NCT01407237 -
Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV
|
N/A | |
| Completed |
NCT01606722 -
Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy
|
N/A | |
| Active, not recruiting |
NCT02411071 -
Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment Regimens
|
N/A | |
| Completed |
NCT01417949 -
Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events
|
Phase 4 |